Advancement of the study on iron metabolism and regulation in tumor cells

Chinese Journal of Cancer

Volumn 29, Issue 4, 2010, Pages 451-455

  Wang, Shu Jun ^a   Gao, Chong ^a   Chen, Bao An ^a  

^a SOUTHEAST UNIVERSITY   (China)

Author keywords

Ferritin; Hepcidin; Iron metabolism; Transferrin receptor; Transferring; Tumor

Indexed keywords

CD71 ANTIGEN; FERRITIN; GAMBOGIC ACID; HEPCIDIN; POLYETHYLENEIMINE; TRANSFERRIN; TRANSFERRIN RECEPTOR 2;

APOPTOSIS; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RISK; CANCER THERAPY; COLORECTAL CARCINOMA; DNA SYNTHESIS; ELECTRON TRANSPORT; HUMAN; IRON METABOLISM; IRON STORAGE; IRON TRANSPORT; KIDNEY CARCINOMA; LIVER CANCER; LUNG CANCER; OXYGEN TRANSPORT; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN SYNTHESIS; PROTEIN TARGETING; REGULATORY MECHANISM; REVIEW; STOMACH CANCER; TUMOR CELL; TUMOR GROWTH; UPREGULATION;

EID: 78249275093     PISSN: 1000467X     EISSN: 1944446X     Source Type: Journal    
DOI: 10.5732/cjc.009.10716     Document Type: Review

References (34)

1. Huang X. Iro n overload and its association with cancer risk in humans: evidence for iron as a carcinogenic metal [J]. Mutat Res, 2003, 533 (1-2):153-171.
2. Wei W, He JM, Wang LW, et al. Study on the relationship between iron metabolism situation and the quality of life in tumor associated anemia patients [J]. Chin Clin Oncol, 2009,14(4):350-353.[in Chinese]
3. Park S, Yoon SY, Kim KE, et al. Interleukin-18 induces transferring expression in breast cancer cell line MCF-7 [J]. Cancer Lett, 2009, 286 (2):189-95.
4. Farias-Eisner G, Su F, Robbins T, et al. Validation of serum biomarkers for detection of early-st age and late-st age endometrial cancer [J]. Am J Obstet Gynecol, 2010, 202(1):73.
5. Liu GH, Ye SN, Yang SH, et al. Transferring-po lythylenimine as a tumor- targeted vector for murine interleukin-12 gene transfer to the mouse osteosareoma cells [J]. Chin J Exp Surg, 2006,23 (12):1519-1521.[in Chinese]
6. Calzolari A, Oliviero I, Deaglio S, et al. Transferrin receptor 2 is frequently expressed in human cancer cell lines [J]. Blood Cells Mol Dis, 2007, 39(1):82-91.
7. Trowbridge IS, Lopez F. Monoclonal antibody to transferrin receptor blocks transferrin binding and inhibits human tumor cell growth in vitro [J]. Proc Natl Acad Sci U S A, 1982, 79(4):1175-1179.
8. Hän ninen MM, Haapasalo J, Haapasalo H, et al. Expression of iron- related genes in human brain and brain tumors [J]. BMC Neurosci, 2009, 10:36.
9. Boult J, Roberts K, Brookes MJ, et al. Overexpression of cellular iron import proteins is associated with malignant progression of esophageal adenocarcinoma [J]. Clin Cancer Res, 2008, 14(2):379-387.
10. O'Donnell KA, Yu D, Zeller KI, et al. Activation of transferrin receptor 1 by c-m yc enhances cellular proliferation and tumorigenesis [J]. Mol Cell Biol, 2006, 26(6):2373-2386.
11. Lepelletier Y, Camara-Clayette V, Jin H, et al. Prevention of mantle lymphoma tumor establishment by routing transferrin receptor toward lysosomal compartments [J]. Cancer Res, 2007, 67(3):1145-1154.
12. Lesnikov V, Lesnikova M, Deeg HJ. Pro-ap optotic and anti-ap optotic effects of transferrin and transferring-de rived glycans on hematopietic cells and lymphocytes [J]. Exp Hematol, 2001, 29(4):477.
13. Pandey MK, Sung B, Ahn KS, et al. Gambogic acid, a novel ligand for transferrin receptor, potentiates TNF-in duced apoptosis through modulation of the nuclear factor-ka ppaB signaling pathway [J]. Blood, 2007, 110(10):3517-3525.
14. Xu X, Sutak R, Richardson DR. Iron chelation by clinically relevant anthracyclines: alteration in expression of iron-re gulated genes and atypical changes in intracellular iron distribution and trafficking [J]. Mol Pharmacol, 2008, 73(3):833-844.
15. Sanchez M, Galy B, Dandekar T, et al. Iron regulation and the cell cycle: identification of an iron-re sponsive element in the 3'-un translated region of human cell division cycle 14A mRNA by a refined microarray-based screening strategy [J]. J Biol Chem, 2006, 281(32):22865-22874.
16. Wallace DF, Summerville L, Lusby PE, et al. First phenotypic description of transferrin receptor 2 knockout mice, and the role of hepcidin [J]. Gut, 2005, 54(7):980-986.
17. Johnson MB, Chen J, Murchison N, et al. Transferrin receptor 2:evidence for ligand-in duced stabilization and redirection to recycling pathway [J]. Mol Biol Cell, 2007, 18(3):743-754.
18. Richardson DR, Kalinowski DS, Lau S, et al. Cancer cell iron metabolism and the development of potent iron chelators as anti-tu mor agents [J]. Biochim Biophys Acta, 2009, 1790(7):702-717.
19. Li LQ, Dong ZN, Tian YP. Assessment of serum ferritin and other four tumor markers in lung cancer [J]. Labeled Immunoassays and Clin Med, 2009,16(2): 68-70. [in Chinese]
20. Zhang J, Liu YM, Zhang W, et al. The value of serum ferritin in dignosis of tumors [J]. Medical Journal of the Chin People's Armed Police Forces, 2007,18(1): 74-75.[in Chinese]
21. Zhang F, Wang W, Tsuji Y, et al. Post-tra nscriptional Modulation of Iron Homeostasis during p53-de pendent Growth Arrest [J]. J Biol Chem, 2008, 283(49):33911-33918.
22. Coffman LG, Parsonage D, D'Agostino R Jr, et al. Regulatory effects of ferritin on angiogenesis [J]. PNAS, 2009, 106(2):570-575.
23. Ukarma L, Johannes H, Beyer U, et al. Hepcidin as a predictor of response to epoetin therapy in anemic cancer patients [J]. Clin Chem, 2009, 55(7):1354-1360.
24. Sun XF, Zhou DB, Zhao YQ. An iron regulator hepcidin is affected by EPO [J]. J Exp Hematol, 2006,14(4):778-782.[in Chinese]
25. Kamai T, Tomosugi N, Abe H, et al. Increased serum hepcidin-25 level and increased tumor expression of hepcidin mRNA are associated with metastasis of renal cell carcinoma [J]. BMC Cancer, 2009, 9:270.
26. Ward DG, Roberts K, Brookes MJ, et al. Increased hepcidin expression in colorectal carcinogenesis [J]. World J Gastroenterol, 2008, 14 (9): 1339-1345.
27. Kijima H, Sawada T, Tomosugi N, et al. Expression of hepcidin mRNA is uniformly suppressed in hepatocellular carcinoma [J]. BMC Cancer, 2008, 8:167.
28. Wallace DF, Summerville L, Lusby PE, et al. First phenotypic description of transferrin receptor 2 knockout mouse, and the role of hepcidin [J]. Gut, 2005, 54(7):980-986.
29. Nemeth E, Rivera S, Gabayan V, et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin [J]. J Clin Invest, 2004, 113(9):1271-1276.
30. Iimura Y, Saito K, Fujii Y, et al. Development and external validation of a new outcome prediction model for patients with clear cell renal cell carcinoma treated with nephrectomy based on preoperative serum C- reactive protein and TNM classification: The TNM-C Score [J]. J Urol, 2009, 181(3):1004-1012.
31. Saito K, Tatokoro M, Fujii Y, et al. Impact of C-re active protein kinetics on survival of patientwith metastatic renal cell carcinoma [J]. Eur Urol, 2009,55(5):1145-1153.
32. Weizer-Stern O, Adamsky K, Margalit O, et al. Hepcidin, a key regulator of iron metabolism, is transcriptionally activated by p53 [J]. Br J Haematol, 2007, 138(2):253-262.
33. Goss JA, Seu P, Gao FQ, et al. Ischemia-re perfusion of rat liver modulates hepcidin in vivo expression [J]. Liver Transpl, 2005, 11 (7): 800-806.
34. Jiang Z, Chen BA, Wu Q, et al. Reversal effect of Fe3O4-m agnetic nanoparticles on multi-dr ug resistance of ovarian carcinoma cells and its correlation with apoptosis-as sociated genes [J]. Chin J Cancer, 2009,28 (11):1158-1162.[in Chinese]